Cue Biopharma Inc. (NASDAQ:CUE) went down by -3.89% during the previous trading session, and it is maintaining the win ahead of Friday’s trading session. The share price of the Biotechnology giant went up by $23.48 to trade ended Friday trading at $24.43. This is down from the $24.43 price recorded on Thursday’s trading session. Thanks to this latest performance, CUE is closer to the higher price 52-week target of $34.00 and further from the lowest price target of $30.00. Its performance from the start of the year has also been positive, with CUE up by 47.91% year-to-date.
Cue Biopharma Inc. (CUE) started the day trading at $24.2 and recorded an intraday high of $26.16. It also recorded an intraday low of $23.1 during Friday’s trading session. Cue Biopharma Inc. is a very active stock that recorded a trading volume that is more than 78.57% of the average daily trading volume on Friday. The stock’s trading volume on Friday was 1627762, which is more than 78.57 of the total average daily trading volume of 348.91K.
Cue Biopharma Inc. (NASDAQ:CUE) 2020 Performance Impressive
The increase in CUE’s stock price on Friday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of CUE currently stands at $31.69, which is higher than the current trading price of the stock by 25.91%. However, CUE’s current trading price is -259.02% lower than the 52-week low price of $6.54. In terms of trading volume, Cue Biopharma Inc. currently experienced healthy participation during the last trading session. 1627762 shares of Cue Biopharma Inc. were traded on the stock exchange on Friday, which is more than 78.57% of the 348.91K average trading volume of the stock.
The performance of the stock has been positive over the past year. CUE’s performance over the past one year has seen it surge by 202.97%, while the stock has gone up by 34.79% in the last six months. The quarterly performance of CUE currently stands at 77.48%, and it is down by -13.77% in the last month. The only negative figure was from the weekly performance, which currently reads -2.37%. At the time of writing CUE’s report, the company has a total market cap of $695.01M, making it one of the largest publicly-traded companies in the world.Cue Biopharma Inc. also has over 45 employees all over the world.
CUE Insider Activities
For Cue Biopharma Inc., insiders hold 49.70% of all company shares. The insider transactions over the past six months are up by 0.40%. During that period, insiders bought 24,166 shares in 3 transactions. In that same period, insiders sold 21,054 of their shares in 3 transactions. After these transactions, insiders at Cue Biopharma Inc. now hold 4.33M shares, which is over 43.42% of the total company stocks. Institutional investors currently hold a large chunk of the CUE shares, as they control 15.23% of the company’s total stock.
CUE Fundamental Analysis
For Cue Biopharma Inc., the stock’s diluted earnings per share (EPS) stands at -1.62. In the coming year, analysts expect the EPS to be -1.74.
The Return on Investment (ROI) on Cue Biopharma Inc.’s stock currently stands at -68.10%.
CUE Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of CUE currently stands at -10.50%, while the SMA50 is -8.95%. The biggest one is the SMA200, which is currently reading 44.68% ahead of Friday’s trading session. The Relative Strength Index of this stock is 41.43.